A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results

被引：0
|
作者：
Sym, S.
Park, S.
Park, J.
Kwon, K.
Jung, I.
Cho, E.
Lee, W.
Chung, M.
Shin, D.
Lee, J.
机构：
[1] Gachon Univ, Gil Hosp, Inchon, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4566
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results
    Sym, S.
    Park, S.
    Park, J.
    Park, Y.
    Jung, I.
    Cho, E.
    Lee, W.
    Chung, M.
    Shin, D.
    Lee, J.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 383 - 383
  • [2] Phase II trial of weekly docetaxel/fluorouracil/cisplatin in patients with advanced gastric cancer: Preliminary results
    Evangelista, W.
    Racca, P.
    Fanchini, L.
    Ritorto, G.
    Ciorba, A.
    Facilissimo, I
    Napoletano, R.
    Fusco, V
    Alabiso, O.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 48 - 48
  • [3] A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
    Kim, Young Saing
    Sym, Sun Jin
    Park, Se Hoon
    Park, Inkeun
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Jinny
    Cho, Eun Kyung
    Lee, Woon Ki
    Chung, Min
    Lee, Jae Hoon
    Shin, Dong Bok
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 163 - 169
  • [4] A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer
    Young Saing Kim
    Sun Jin Sym
    Se Hoon Park
    Inkeun Park
    Junshik Hong
    Hee Kyung Ahn
    Jinny Park
    Eun Kyung Cho
    Woon Ki Lee
    Min Chung
    Jae Hoon Lee
    Dong Bok Shin
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 73 : 163 - 169
  • [5] Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer
    Jung, K. S.
    Song, H. N.
    Yoo, K. H.
    Cho, J.
    Kim, S. T.
    Lee, J.
    Park, S. H.
    Park, Y. S.
    Lim, H. Y.
    Kang, W. K.
    Park, J. O.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S438 - S439
  • [6] Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer
    Kim, Seung Tae
    Lee, Jeeyun
    Lee, Su Jin
    Park, Se Hoon
    Jung, Sin-Ho
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Joon Oh
    [J]. ONCOTARGET, 2016, 7 (17) : 24088 - 24096
  • [7] MULTICENTER RANDOMIZED PHASE II STUDY OF WEEKLY DOCETAXEL ALONE VERSUS WEEKLY DOCETAXEL PLUS OXALIPLATIN AS A SECOND-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER: PRELIMINARY RESPONSE AND SAFETY RESULTS
    Kim, J. Y.
    Do, Y. R.
    Park, K. U.
    Ryoo, H. -M.
    Bae, S. H.
    Chae, Y. S.
    Kim, M. K.
    Lee, K. H.
    Lee, S. A.
    Kim, J. G.
    Song, H. -S.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 20 - 20
  • [8] Multicenter randomized phase II study of weekly docetaxel alone versus weekly docetaxel plus oxaliplatin as a second-line chemotherapy in patients with advanced gastric cancer: Preliminary response and safety results
    Kim, Jin Young
    Do, Young Rok
    Park, Keon Uk
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    Chae, Yee Soo
    Kim, Min Kyoung
    Lee, Kyung Hee
    Lee, Sun Ah
    Kim, Jong Gwang
    Song, Hong-Suk
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer.
    Lee, Min-Young
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Joon Oh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
    Sym, Sun Jin
    Ryu, Min-Hee
    Kang, Hye Jin
    Lee, Sung Sook
    Chang, Heung-Moon
    Lee, Jae Lyun
    Kim, Tae Won
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 373 - 380
12345